NP49425 Generic and Biosimilar Transition Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-0581ea32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
75
Lots
10
10 awarded
Published
19 Dec 2025
Total lots
10
Awarded
10
0 pending
Estimated total
£235.0m
Awarded total
—
Lot 1cancelled
Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)
Award value
—
Start
01 Feb 2026
End
28 Feb 2027
Estimated
£100.0m
CPV
33600000
Awarded to 5 suppliers
Lot 2cancelled
Cytokine Modulators (Omalizumab)
Award value
—
Start
31 Mar 2026
End
28 Feb 2027
Estimated
£15.6m
CPV
33600000
Awarded to 2 suppliers
Lot 3cancelled
Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines
Award value
—
Start
01 Feb 2026
End
31 Jul 2027
Estimated
£26.2m
CPV
33600000
Awarded to 20 suppliers
ML
SS
Lot 4cancelled
Denosumab (Osteoporosis) and Ferric Carboxymaltose
Award value
—
Start
01 Feb 2026
End
31 Jul 2027
Estimated
£27.4m
CPV
33600000
Lot 5cancelled
Apremilast
Award value
—
Start
01 Feb 2026
End
31 Oct 2027
Estimated
£1.5m
CPV
33600000
Awarded to 4 suppliers
Lot 6cancelled
Cardiovascular and Respiratory Medicines
Award value
—
Start
01 Feb 2026
End
30 May 2028
Estimated
£457k
CPV
33600000
Awarded to 7 suppliers
Lot 7cancelled
Nintedanib
Award value
—
Start
31 Mar 2026
End
30 May 2028
Estimated
£27.3m
CPV
33600000
Awarded to 6 suppliers
Lot 8cancelled
Cancer Medicines (Group 1)
Award value
—
Start
01 Feb 2026
End
31 Jan 2027
Estimated
£15.2m
CPV
33600000
Awarded to 7 suppliers
PF
Lot 9cancelled
Cancer Medicines (Group 2)
Award value
—
Start
01 Feb 2026
End
31 Jan 2027
Estimated
£21.3m
CPV
33600000
Lot 10cancelled
Psychiatry and Neurology Medicines
Award value
—
Start
01 Feb 2026
End
30 Sept 2028
Estimated
£61k
CPV
33600000